e10vq
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 10-Q
(MARK ONE)
     
þ   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2007
or
     
o   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                     
Commission file number 0-23621
MKS INSTRUMENTS, INC.
(Exact name of registrant as specified in its charter)
     
Massachusetts   04-2277512
 
(State or other jurisdiction
of incorporation or organization)
  (I.R.S. Employer
Identification No.)
     
90 Industrial Way, Wilmington, Massachusetts   01887
 
(Address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code (978) 284-4000
     Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o
     Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer  þ           Accelerated filer o           Non-accelerated filer o
     Indicate by check mark whether the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.
     Yes o No þ
     Number of shares outstanding of the issuer’s common stock as of July 30, 2007: 57,537,258
 
 

 


 

MKS INSTRUMENTS, INC.
FORM 10-Q
INDEX
                 
PART I.   FINANCIAL INFORMATION        
 
               
 
  ITEM 1.   FINANCIAL STATEMENTS.        
 
               
 
      Consolidated Balance Sheets — June 30, 2007 and December 31, 2006     3  
 
               
 
      Consolidated Statements of Operations — Three and six months ended June 30, 2007 and 2006     4  
 
               
 
      Consolidated Statements of Cash Flows — Six months ended June 30, 2007 and 2006     5  
 
               
 
      Notes to Consolidated Financial Statements     6  
 
               
 
  ITEM 2.   MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.     11  
 
               
 
  ITEM 3.   QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.     16  
 
               
 
  ITEM 4.   CONTROLS AND PROCEDURES.     16  
 
               
PART II.   OTHER INFORMATION        
 
               
 
  ITEM 1.   LEGAL PROCEEDINGS.     17  
 
               
 
  ITEM 1A.   RISK FACTORS.     17  
 
               
 
  ITEM 2.   UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.     17  
 
               
 
  ITEM 4.   SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.     17  
 
               
 
  ITEM 6.   EXHIBITS.     18  
 
               
 
  SIGNATURES.        
 
               
    EXHIBIT INDEX        
 EX-31.1 Section 302 Certification of PEO
 EX-31.2 Section 302 Certification of PFO
 EX-32.1 Section 906 Certification of CEO and CFO

2


Table of Contents

PART I.   FINANCIAL INFORMATION
     ITEM 1.  FINANCIAL STATEMENTS.
MKS INSTRUMENTS, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands, except share data)
                 
    June 30, 2007     December 31, 2006  
    (unaudited)          
ASSETS
               
Current assets:
               
Cash and cash equivalents
  $ 221,153     $ 215,208  
Short-term investments
    114,923       74,749  
Trade accounts receivable, net
    125,910       123,658  
Inventories
    163,713       149,820  
Deferred income taxes
    16,376       16,787  
Other current assets
    15,652       11,216  
 
           
Total current assets
    657,727       591,438  
 
               
Property, plant and equipment, net
    80,130       79,463  
Long-term investments
    6,729       2,816  
Goodwill
    322,712       323,973  
Acquired intangible assets, net
    35,998       43,104  
Other assets
    2,376       2,926  
 
           
Total assets
  $ 1,105,672     $ 1,043,720  
 
           
 
               
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
Current liabilities:
               
Short-term borrowings
  $ 24,038     $ 21,845  
Current portion of capital lease obligations
    1,383       1,176  
Accounts payable
    37,938       38,541  
Accrued compensation
    17,642       26,685  
Income taxes payable
          16,619  
Other accrued expenses
    30,534       25,031  
 
           
Total current liabilities
    111,535       129,897  
 
               
Long-term debt
    5,000       5,000  
Long-term portion of capital lease obligations
    1,135       1,113  
Deferred income taxes
    2,727       1,535  
Other liabilities
    17,412       4,956  
Commitments and contingencies (Note 8)
               
 
               
Stockholders’ equity:
               
Preferred Stock, $0.01 par value, 2,000,000 shares authorized; none issued and outstanding
           
Common Stock, no par value, 200,000,000 shares authorized; 57,687,601 and 56,671,625 shares issued and outstanding at June 30, 2007 and December 31, 2006, respectively
    113       113  
Additional paid-in capital
    714,034       680,164  
Retained earnings
    243,479       210,877  
Accumulated other comprehensive income
    10,237       10,065  
 
           
Total stockholders’ equity
    967,863       901,219  
 
           
Total liabilities and stockholders’ equity
  $ 1,105,672     $ 1,043,720  
 
           
The accompanying notes are an integral part of the consolidated financial statements.

3


Table of Contents

MKS INSTRUMENTS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(Unaudited)
                                 
    Three Months Ended     Six Months Ended  
    June 30     June 30,  
    2007     2006     2007     2006  
 
                               
Net sales
  $ 203,978     $ 198,351     $ 415,410     $ 377,412  
Cost of sales
    117,948       111,850       236,518       217,166  
 
                       
Gross profit
    86,030       86,501       178,892       160,246  
 
                               
Research and development
    18,351       17,663       36,650       33,720  
Selling, general and administrative
    35,928       30,300       70,504       60,065  
Amortization of acquired intangible assets
    4,108       4,086       8,215       9,340  
Purchase of in-process technology
                      800  
 
                       
Income from operations
    27,643       34,452       63,523       56,321  
Interest expense
    216       228       433       431  
Interest income
    3,797       2,162       7,319       3,795  
 
                       
Income before income taxes
    31,224       36,386       70,409       59,685  
Provision for income taxes
    8,697       12,012       20,592       19,876  
 
                       
Net income
  $ 22,527     $ 24,374     $ 49,817     $ 39,809  
 
                       
 
                               
Net income per share:
                               
Basic
  $ 0.40     $ 0.44     $ 0.88     $ 0.72  
 
                       
Diluted
  $ 0.39     $ 0.44     $ 0.86     $ 0.72  
 
                       
 
                               
Weighted average common shares outstanding:
                               
Basic
    56,820       55,338       56,587       54,999  
 
                       
Diluted
    57,939       55,907       57,633       55,588  
 
                       
The accompanying notes are an integral part of the consolidated financial statements.

4


Table of Contents

MKS INSTRUMENTS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(Unaudited)
                 
    Six Months Ended  
    June 30,  
    2007     2006  
 
               
Cash flows from operating activities:
               
Net income
  $ 49,817     $ 39,809  
Adjustments to reconcile net income to net cash provided by operating activities:
               
Depreciation and amortization
    15,435       15,882  
Stock-based compensation
    6,895       5,980  
Tax benefit from stock-based compensation
    2,511       3,865  
Excess tax benefit from stock-based compensation
    (1,025 )     (1,829 )
Other
    1,504       829  
Changes in operating assets and liabilities, net of businesses acquired:
               
Trade accounts receivable
    (2,739 )     (28,351 )
Inventories
    (14,154 )     (23,999 )
Other current assets
    (4,825 )     (517 )
Accrued expenses and other current liabilities
    8,983       11,596  
Accounts payable
    (560 )     4,427  
Income taxes payable
    (16,671 )     (2,924 )
 
           
Net cash provided by operating activities
    45,171       24,768  
 
           
 
               
Cash flows from investing activities:
               
Acquisitions of businesses, net of cash acquired
          (96,672 )
Purchases of short-term and long-term available for sale investments
    (113,809 )     (45,064 )
Maturities and sales of short-term and long-term available for sale investments
    69,721       65,280  
Purchases of property, plant and equipment
    (6,898 )     (4,210 )
Other
    557       (756 )
 
           
Net cash used in investing activities
    (50,429 )     (81,422 )
 
           
 
               
Cash flows from financing activities:
               
Proceeds from short-term borrowings
    56,992       42,417  
Payments on short-term borrowings
    (53,943 )     (36,357 )
Repurchases of common stock
    (31,719 )      
Principal payments on long-term debt and capital lease obligations
    (640 )     (1,933 )
Proceeds from exercise of stock options and employee stock purchase plan
    38,968       16,560  
Excess tax benefit from stock-based compensation
    1,025       1,829  
 
           
Net cash provided by financing activities
    10,683       22,516  
 
           
 
               
Effect of exchange rate changes on cash and cash equivalents
    520       862  
 
           
Increase (decrease) in cash and cash equivalents
    5,945       (33,276 )
Cash and cash equivalents at beginning of period
    215,208       220,573  
 
           
Cash and cash equivalents at end of period
  $ 221,153     $ 187,297  
 
           
 
               
Supplemental cash flow disclosure:
               
Income taxes paid
  $ 24,108     $ 17,858  
 
           
The accompanying notes are an integral part of the consolidated financial statements.

5


Table of Contents

MKS INSTRUMENTS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tables in thousands, except share and per share data)
1)   Basis of Presentation
 
    The terms “MKS” and the “Company” refer to MKS Instruments, Inc. and its subsidiaries. The interim financial data as of June 30, 2007 and for the three and six months ended June 30, 2007 and 2006 is unaudited; however, in the opinion of MKS, the interim data includes all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the results for the interim periods. The unaudited consolidated financial statements presented herein have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America. The consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the MKS Annual Report on Form 10-K for the year ended December 31, 2006 filed with the Securities and Exchange Commission on February 28, 2007.
 
    The preparation of these consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. On an on-going basis, management evaluates its estimates and judgments, including those related to revenue recognition, stock-based compensation, inventory, intangible assets, goodwill and other long-lived assets, in-process research and development expenses, merger expenses, income taxes and investments. Management bases its estimates and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
 
    Certain amounts in prior periods have been reclassified to be consistent with the current period presentation.
 
2)   Goodwill and Intangible Assets
 
    Intangible Assets
 
    Acquired amortizable intangible assets consisted of the following as of June 30, 2007:
                         
    Gross Carrying     Accumulated     Net Carrying  
    Amount     Amortization     Amount  
Completed technology
  $ 87,706     $ (69,584 )   $ 18,122  
Customer relationships
    21,242       (8,487 )     12,755  
Patents, trademarks, tradenames and other
    16,674       (11,553 )     5,121  
 
                 
 
  $ 125,622     $ (89,624 )   $ 35,998  
 
                 
    Acquired amortizable intangible assets consisted of the following as of December 31, 2006:
                         
    Gross Carrying     Accumulated     Net Carrying  
    Amount     Amortization     Amount  
Completed technology
  $ 87,087     $ (63,570 )   $ 23,517  
Customer relationships
    20,932       (7,139 )     13,793  
Patents, trademarks, tradenames and other
    16,494       (10,700 )     5,794  
 
                 
 
  $ 124,513     $ (81,409 )   $ 43,104  
 
                 
    Aggregate amortization expense related to acquired intangibles for the three and six months ended June 30, 2007 was $4,108,000 and $8,215,000, respectively. Aggregate amortization expense related to acquired intangibles for the three and six months ended June 30, 2006 was $4,086,000 and $9,340,000, respectively. Estimated amortization expense related to acquired intangibles for the remainder of 2007 and in total for the year is $7,554,000 and $15,769,000, respectively. Estimated amortization expense for 2008 and for each of the three succeeding fiscal years is as follows:
         
Year   Amount
2008
  $ 8,096  
2009
    5,835  
2010
    4,742  
2011
    4,327  

6


Table of Contents

MKS INSTRUMENTS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (continued)
(Tables in thousands, except share and per share data)
    Goodwill
 
    The changes in the carrying amount of goodwill during the six months ended June 30, 2007 were not material.
3)   Net Income Per Share
 
    The following table sets forth the computation of basic and diluted net income per share:
                                 
    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2007     2006     2007     2006  
 
                               
Numerator:
                               
Net income
  $ 22,527     $ 24,374     $ 49,817     $ 39,809  
 
                       
Denominator:
                               
Shares used in net income per common share — basic
    56,820       55,338       56,587       54,999  
Effect of dilutive securities:
                               
Stock options, restricted stock units and employee stock purchase plan
    1,119       569       1,046       589  
 
                       
Shares used in net income per common share — diluted
    57,939       55,907       57,633       55,588  
 
                       
Net income per common share:
                               
Basic
  $ 0.40     $ 0.44     $ 0.88     $ 0.72  
 
                       
Diluted
  $ 0.39     $ 0.44     $ 0.86     $ 0.72  
 
                       
    For purposes of computing diluted net income per common share, 1,997,191 and 2,744,392 outstanding options for the three and six months ended June 30, 2007, respectively, and 4,783,409 and 4,745,550 outstanding options for the three and six months ended June 30, 2006, respectively, were excluded from the calculation as their inclusion would be anti-dilutive. There were options to purchase approximately 5,393,854 and 8,208,548 shares of the Company’s common stock outstanding as of June 30, 2007 and 2006, respectively.
 
4)   Inventories
 
    Inventories consist of the following:
                 
    June 30,     December 31,  
    2007     2006  
Raw material
  $ 83,513     $ 82,007  
Work in process
    31,041       26,943  
Finished goods
    49,159       40,870  
 
           
 
  $ 163,713     $ 149,820  
 
           
5)   Stockholders’ Equity
    Comprehensive Income
 
    Components of comprehensive income were as follows:
                                 
    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2007     2006     2007     2006  
Net income
  $ 22,527     $ 24,374     $ 49,817     $ 39,809  
Other comprehensive income (loss):
                               
Changes in value of financial instruments designated as cash flow hedges (net of tax of $90 and $0 for the three months ended June 30, respectively, and net of tax benefit of $91 and $271 for the six months ended June 30, respectively)
    148             (154 )     (452 )
Foreign currency translation adjustment
    (95 )     960       255       1,830  
Unrealized gain on investments (net of tax of $26 and $1 for the three months ended June 30, respectively, and net of tax of $42 and $34 for the six months ended June 30, respectively)
    44       3       71       57  
 
                       
Other comprehensive income
    97       963       172       1,435  
 
                       
Total comprehensive income
  $ 22,624     $ 25,337     $ 49,989     $ 41,244  
 
                       

7


Table of Contents

MKS INSTRUMENTS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (continued)
(Tables in thousands, except share and per share data)
    Stock Repurchase Program
 
    On February 12, 2007, MKS’ Board of Directors approved a share repurchase program (the “Program”) for the repurchase of up to $300 million of its outstanding stock over the subsequent two years. The repurchases may be made from time to time on the open market or through privately negotiated transactions. The timing and amount of any shares repurchased under the Program will depend on a variety of factors, including price, corporate and regulatory requirements, capital availability, and other market conditions. The Program may be discontinued at any time at the discretion of the Company and its Board of Directors. During the three months ended June 30, 2007, we repurchased 690,765 shares of common stock for $18,844,288 for an average price of $27.28 and during the six months ended June 30, 2007, we repurchased 1,200,765 shares of common stock for $31,719,084 for an average price of $26.42.
 
 
    Share-Based Compensation
 
    At June 30, 2007, total unrecognized estimated compensation cost related to non-vested stock options, restricted stock and restricted stock units (collectively “stock-based shares”) granted prior to that date was approximately $27,334,564, which is expected to be recognized over a weighted-average period of 2.1 years. Net stock-based shares, after forfeitures and cancellations, granted during the six months ended June 30, 2007 and 2006 represented 1.0% and 1.1%, respectively, of outstanding shares as of the beginning of each fiscal period and represented 1.0% and 1.1%, respectively, of outstanding shares as of the end of each fiscal period.
 
6)   Income Taxes
 
    The Company has adopted FASB Interpretation 48, Accounting for Uncertainty in Income Taxes (“FIN 48”), as of January 1, 2007. As a result of the implementation of FIN 48, the Company recognized no adjustment in the liability for unrecognized income tax benefits. At the adoption date of January 1, 2007, the total amount of gross unrecognized tax benefits, which excludes interest and penalties discussed below, was approximately $10,500,000. If these benefits were recognized in a future period, the timing of which is not estimable, the net unrecognized tax benefit of approximately $10,100,000 would impact the Company’s effective tax rate. The total amount of gross unrecognized tax benefits at June 30, 2007 was approximately $11,700,000. The increase from January 1, 2007 was primarily attributable to tax positions taken by the Company in the current year.
 
    MKS and its subsidiaries are subject to U.S. federal income tax as well as the income tax of multiple state and foreign jurisdictions. The Company has concluded all U.S. federal income tax matters for years through 2002. At June 30, 2007, there were ongoing audits in various other tax jurisdictions. The Company does not expect any material changes to the returns as filed from these open audits.
 
    Within the next four quarters, the statute of limitations will close on the 2001 and 2002 tax returns filed in various foreign jurisdictions. As a result, it is reasonably expected that net unrecognized tax benefits from these foreign jurisdictions may be recognized within the next four quarters. The recognition of these tax benefits is not expected to have a material impact on the Company’s financial statements. The Company does not reasonably expect any other significant changes in the next four quarters. The following tax years, in the major tax jurisdictions noted, are open for assessment or refund: U.S. Federal: 2003 to 2006, Germany: 2002 to 2006, Korea: 2005 and 2006, Japan: 2001 to 2006, and the United Kingdom: 2005 and 2006.
 
    The Company will accrue interest and, if applicable, penalties, for any uncertain tax positions. This interest and penalty expense will be a component of income tax expense. At the date of adoption of FIN 48 and at June 30, 2007, the Company had approximately $700,000 and $1,000,000, respectively, accrued for interest on unrecognized tax benefits.
 
    The Company’s effective tax rate for the three and six months ended June 30, 2007 was 27.9% and 29.2%, respectively. The effective tax rate is less than the statutory tax rate primarily due to the profits of the Company’s international subsidiaries being taxed at rates lower than the U.S. statutory tax rate and the benefit from U.S. research and development credits.
 
7)   Geographic, Product and Significant Customer Information
 
    The Company operates in one segment for the development, manufacturing, sales and servicing of products that measure, control, power and monitor critical parameters of advanced manufacturing processes. The Company’s chief decision-maker reviews consolidated operating results to make decisions about allocating resources and assessing performance for the entire Company.

8


Table of Contents

MKS INSTRUMENTS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (continued)
(Tables in thousands, except share and per share data)
    Information about the Company’s operations in different geographic regions is presented in the tables below. Net sales to unaffiliated customers are based on the location in which the sale originated. Transfers between geographic areas are at negotiated transfer prices and have been eliminated from consolidated net sales.
                                 
    Three Months Ended     Six Months Ended          
    June 30,     June 30,          
    2007     2006     2007     2006      
 
                               
Geographic net sales:
                               
United States
  $ 127,505     $ 133,376     $ 257,852     $ 258,509  
Japan
    27,897       23,947       53,943       46,105  
Europe
    22,009       17,339       42,936       31,871  
Asia
    26,567       23,689       60,679       40,927  
 
                       
 
  $ 203,978     $ 198,351     $ 415,410     $ 377,412  
 
                       
                 
    June 30,     December 31,  
    2007     2006  
 
               
Long-lived assets:
               
United States
  $ 66,841     $ 68,393  
Japan
    5,758       5,479  
Europe
    4,667       4,908  
Asia
    5,240       3,609  
 
           
 
  $ 82,506     $ 82,389  
 
           
    The Company groups its products into three product groups. Net sales for these product groups are as follows:
                                 
    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2007     2006     2007     2006  
Instruments and Control Systems
  $ 97,338     $ 94,316     $ 198,529     $ 178,224  
Power and Reactive Gas Products
    86,813       83,645       172,380       160,229  
Vacuum Products
    19,827       20,390       44,501       38,959  
 
                       
 
  $ 203,978     $ 198,351     $ 415,410     $ 377,412  
 
                       
    The Company had one customer comprising 21% of net sales for the three months ended June 30, 2007 and one customer comprising 20% of net sales for the six months ended June 30, 2007. The Company had one customer comprising 22% of net sales for the three months ended June 30, 2006, and two customers comprising 22% and 10%, respectively, of net sales for the six months ended June 30, 2006.
 
8)   Commitments and Contingencies
 
    The Company is subject to various legal proceedings and claims, which have arisen in the ordinary course of business. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on the Company’s results of operations, financial condition or cash flows.
 
    The Company reviewed its contractual obligations and commercial commitments as of June 30, 2007 and determined that there were no significant changes from the ones set forth in the Company’s Annual Report on Form 10-K for the year ended December 31, 2006. However, certain changes in the Company’s obligations related to the adoption of FIN 48 are discussed in Note 6, Income Taxes, in the Notes to Consolidated Financial Statements in this Form 10-Q.
 
9)   Product Warranties
 
    The Company provides for the estimated costs to fulfill customer warranty obligations upon the recognition of the related revenue. While the Company engages in extensive product quality programs and processes, including actively monitoring and evaluating the quality of its component suppliers, the Company’s warranty obligation is affected by product failure rates, utilization levels, material usage, and supplier warranties on parts delivered to the Company. Should actual product failure rates, utilization levels, material usage, or supplier warranties on parts differ from the Company’s estimates, revisions to the estimated warranty liability would be required.

9


Table of Contents

MKS INSTRUMENTS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (continued)
(Tables in thousands, except share and per share data)
    Product warranty activities for the six months ended June 30 were as follows:
                 
    2007     2006  
Balance at January 1
  $ 11,549     $ 7,766  
Fair value of warranty liabilities acquired during the period
          612  
Provisions for product warranties during the period
    4,020       7,299  
Direct charges to warranty liability during the period
    (4,211 )     (4,606 )
 
           
Balance at June 30
  $ 11,358     $ 11,071  
 
           
10)   Recently Issued Accounting Pronouncements
 
    In September 2006, the Financial Accounting Standards Board (the “FASB”) issued SFAS No. 157, “Fair Value Measurements” (“SFAS 157”). SFAS 157 clarifies the principle that fair value should be based on the assumptions market participants would use when pricing an asset or liability and establishes a fair value hierarchy that prioritizes the information used to develop those assumptions. Under the standard, fair value measurements would be separately disclosed by level within the fair value hierarchy. SFAS 157 is effective for fiscal years beginning after November 15, 2007, with early adoption permitted. MKS is currently in the process of evaluating any potential impact of SFAS 157.
 
    In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Liabilities” (“SFAS 159”). SFAS 159 permits companies to choose to measure certain financial instruments and certain other items at fair value and requires that unrealized gains and losses on items for which the fair value option has been elected be reported in earnings. SFAS 159 is effective for fiscal years beginning after November 15, 2007, although early adoption is permitted. The Company is currently evaluating the impact of SFAS 159 and has not yet determined its possible effect on its consolidated financial statements.

10


Table of Contents

MKS INSTRUMENTS, INC.
     ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
     We believe that this Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. When used herein, the words “believes,” “anticipates,” “plans,” “expects,” “estimates” and similar expressions are intended to identify forward-looking statements. These forward-looking statements reflect management’s current opinions and are subject to certain risks and uncertainties that could cause results to differ materially from those stated or implied. We assume no obligation to update this information. Risks and uncertainties include, but are not limited to those discussed in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2006 filed with the Securities and Exchange Commission on February 28, 2007
Overview
     We are a leading worldwide provider of instruments, components, subsystems and process control solutions that measure, control, power, monitor and analyze critical parameters of semiconductor and other advanced manufacturing processes.
     We are managed as one operating segment which is organized around three product groups: Instruments and Control Systems, Power and Reactive Gas Products and Vacuum Products. Our products are derived from our core competencies in pressure measurement and control, materials delivery, gas and thin-film composition analysis, electrostatic charge control, control and information management, power and reactive gas generation and vacuum technology. Our products are used to manufacture semiconductors and thin film coatings for diverse markets such as flat panel displays, optical and magnetic storage media, architectural glass, solar panels and electro-optical products. We also provide technologies for other markets, including the medical imaging equipment and the energy generation and conservation markets.
     Our customers include semiconductor capital equipment manufacturers, semiconductor device manufacturers, capital equipment manufacturers of thin-film coatings used in flat panel displays, optical and magnetic data storage media, architectural glass, solar panels and electro-optical products, industrial and manufacturing companies, medical equipment manufacturers and university, government and industrial research laboratories. For the six months ended June 30, 2007 and the full year ended December 31, 2006, we estimate that approximately 70% of our net sales, respectively, were to semiconductor capital equipment manufacturers and semiconductor device manufacturers. We expect that sales to the semiconductor capital equipment manufacturers and semiconductor device manufacturers will continue to account for a substantial majority of our sales.
     During 2006, we experienced significant increases in customer orders, which primarily resulted in an increase in our net sales for 2006 to $782.8 million, which ranged quarterly from $179.1 million to $205.5 million, from 2005 net sales of $509.3 million. Orders and net sales during our first two quarters of 2007 continued at a high level resulting in net sales of $211.4 million and $204.0 million for the first and second quarter, respectively. For the third quarter of 2007, we expect that our net sales could be approximately 10% lower than our second quarter 2007 net sales. The semiconductor capital equipment industry is subject to rapid demand shifts, which are difficult to predict, and we are uncertain how long these sales levels may be maintained or the timing or extent of any future downturn or upturn in the semiconductor capital equipment industry.
     A portion of our net sales is attributable to operations in international markets. For the six months ended June 30, 2007 and full year ended December 31, 2006, international sales accounted for approximately 38% and 34% of net sales, respectively.
     On January 3, 2006, we completed our acquisition of Ion Systems, Inc. (“Ion”), a leading provider of electrostatic management solutions located in Alameda, California, pursuant to an Agreement and Plan of Merger dated November 25, 2005. Ion’s ionization technology controls electrostatic charges to reduce process contamination and improve yields, which complements our process monitoring and control technologies. The aggregate purchase price consisted of $68.1 million in cash, net of $5.1 million in cash acquired, and $0.8 million in acquisition related costs.
     Additionally, on January 3, 2006, we completed our acquisition of Umetrics, AB (“Umetrics”), a leader in multivariate data analysis and modeling software located in Umea, Sweden, pursuant to a Sale and Purchase Agreement dated December 15, 2005. Umetrics’ multivariate data analysis and modeling software converts process data into useable information for yield improvement, when linked with our open and modular platform of process sensors and data collection, integration, data storage, and visualization capabilities. The purchase price consisted of $27.4 million in cash, net of $2.6 million in cash acquired, and $0.4 million in acquisition related costs.
Critical Accounting Policies and Estimates
     The preparation of our consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make judgments, assumptions and estimates that affect the amounts reported. There have been no material changes in our critical accounting policies since December 31, 2006. For further

11


Table of Contents

information, please see the discussion of critical accounting policies in our Annual Report on Form 10-K for the year ended December 31, 2006.
Results of Operations
     The following table sets forth, for the periods indicated, the percentage of total net sales of certain line items included in MKS’ consolidated statements of operations data.
                                 
    Three Months Ended   Six Months Ended
    June 30,   June 30,
    2007   2006   2007   2006
Net sales
    100.0 %     100.0 %     100.0 %     100.0 %
Cost of sales
    57.8       56.4       56.9       57.5  
 
                               
Gross profit
    42.2       43.6       43.1       42.5  
Research and development
    9.0       8.9       8.8       8.9  
Selling, general and administrative
    17.6       15.3       17.0       15.9  
Amortization of acquired intangible assets
    2.0       2.0       2.0       2.5  
Purchase of in-process technology
                      0.3  
 
                               
Income from operations
    13.6       17.4       15.3       14.9  
Interest income, net
    1.7       1.0       1.7       0.9  
 
                               
Income before income taxes
    15.3       18.4       17.0       15.8  
Provision for income taxes
    4.3       6.1       5.0       5.3  
 
                               
Net income
    11.0 %     12.3 %     12.0 %     10.5 %
 
                               
Net Sales (dollars in millions)
                                                   
    Three Months Ended     Six Months Ended
    June 30,     June 30,
    2007   2006   % Change     2007   2006   % Change
Net sales
  $ 204.0     $ 198.4       2.8       $ 415.4     $ 377.4       10.1  
     Net sales increased $5.6 million during the three month period ended June 30, 2007 mainly due to an increase in worldwide demand from our thin-film and other non-semiconductor manufacturing applications, which sales increased $8.1 million or 14.0% compared to the same period for the prior year offset by a decrease in sales to our semiconductor capital equipment manufacturer and semiconductor device manufacturer customers of $2.5 million or 1.8% compared to the same period for the prior year. International net sales were approximately $76.5 million for the three months ended June 30, 2007 or 37.5% of net sales compared to $65.0 million for the three months ended June 30, 2006 or 32.8% of net sales.
     Net sales increased $38.0 million during the six month period ended June 30, 2007 mainly due to an increase in worldwide demand from our semiconductor capital equipment manufacturer and semiconductor device manufacturer customers, which sales increased $22.8 million or 8.5% compared to the same period for the prior year and from our other non-semiconductor manufacturing applications, which sales increased $15.0 million or 19.1% compared to the same period for the prior year. International net sales were approximately $157.6 million for the six months ended June 30, 2007 or 37.9% of net sales compared to $118.9 million for the six months ended June 30, 2006 or 31.5% of net sales.
Gross Profit
                                                   
    Three Months Ended     Six Months Ended
    June 30,     June 30,
                    % Points                     % Points
    2007   2006   Change     2007   2006   Change
Gross profit as a percentage of net sales
    42.2 %     43.6 %     (1.4 )       43.1 %     42.5 %     0.6  
     Gross profit decreased by approximately 1.4 percentage points during the three months ended June 30, 2007 consisting of approximately 1.3 percentage points from higher overhead, 0.7 percentage points from higher costs related to excess and obsolete inventory and 0.5 percentage points from changes in product mix, offset primarily by 0.9 percentage points from reduced warranty costs.
     Gross profit increased by approximately 0.6 percentage points during the six months ended June 30, 2007 primarily consisting of approximately 1.1 percentage points from increased sales volume and 0.9 percentage points from lower warranty costs, offset by 1.2 percentage points from higher overhead, 0.5 percentage points from higher costs related to excess and obsolete inventory and the remainder from a combination of changes in product mix and foreign currency fluctuations.

12


Table of Contents

Research and Development (dollars in millions)
                                                   
    Three Months Ended     Six Months Ended
    June 30,     June 30,
    2007   2006   % Change     2007   2006   % Change
Research and development expenses
  $ 18.4     $ 17.7       3.9       $ 36.7     $ 33.7       8.7  
     Research and development expense increased $0.7 million during the three months ended June 30, 2007 mainly due to increased compensation expense of $0.6 million, as a result of higher staffing and compensation levels.
     Research and development expense increased $3.0 million during the six months ended June 30, 2007 mainly due to increased compensation expense of $2.0 million, as a result of higher staffing and compensation levels.
     Our research and development is primarily focused on developing and improving our instruments, components, subsystems and process control solutions to improve process performance and productivity.
     We have hundreds of products and our research and development efforts primarily consist of a large number of projects related to these products, none of which is individually material to us. Current projects typically have a duration of 12 to 30 months depending upon whether the product is an enhancement of existing technology or a new product. Our current initiatives include projects to enhance the performance characteristics of older products, to develop new products and to integrate various technologies into subsystems. These projects support in large part the transition in the semiconductor industry to larger wafer sizes and smaller integrated circuit geometries, which require more advanced process control technology. Research and development expenses consist primarily of salaries and related expenses for personnel engaged in research and development, fees paid to consultants, material costs for prototypes and other expenses related to the design, development, testing and enhancement of our products.
     We believe that the continued investment in research and development and ongoing development of new products are essential to the expansion of our markets, and expect to continue to make significant investment in research and development activities. We are subject to risks if products are not developed in a timely manner, due to rapidly changing customer requirements and competitive threats from other companies and technologies. Our success primarily depends on our products being designed into new generations of equipment for the semiconductor industry. We develop products that are technologically advanced so that they are positioned to be chosen for use in each successive generation of semiconductor capital equipment. If our products are not chosen to be designed into our customers’ products, our net sales may be reduced during the lifespan of those products.
Selling, General and Administrative (dollars in millions)
                                                   
    Three Months Ended     Six Months Ended
    June 30,     June 30,
    2007   2006   % Change     2007   2006   % Change
Selling, general and administrative expenses
  $ 35.9     $ 30.3       18.6       $ 70.5     $ 60.1       17.4  
     Selling, general and administrative expenses increased $5.6 million for the three months ended June 30, 2007 due to $2.3 million in foreign exchange rate gains in 2006 that did not occur in 2007, $2.1 million of additional costs related to our ongoing enterprise resource planning system implementation and a $1.0 million increase in compensation costs resulting from increased headcount and compensation and benefit costs.
     Selling, general and administrative expenses increased $10.4 million for the six months ended June 30, 2007 due to $3.6 million in foreign exchange rate gains primarily occurring in 2006 that did not occur in 2007, $4.0 million of additional costs related to our ongoing enterprise resource planning system implementation and a $2.1 million increase in compensation costs resulting from increased headcount and compensation and benefit costs.
Amortization of Acquired Intangible Assets (dollars in millions)
                                                   
    Three Months Ended     Six Months Ended
    June 30,     June 30,
    2007   2006   % Change     2007   2006   % Change
Amortization of acquired intangible assets
  $ 4.1     $ 4.1             $ 8.2     $ 9.3       (12.0 )

13


Table of Contents

     Amortization expense for the six months ended June 30, 2007 decreased $1.1 million primarily as a result of certain acquired intangible assets that were fully amortized during the first quarter of 2006.
Interest Income, Net (dollars in millions)
                                                   
    Three Months Ended     Six Months Ended
    June 30,     June 30,
    2007   2006   % Change     2007   2006   % Change
Interest income, net
  $ 3.6     $ 1.9       85.2       $ 6.9     $ 3.4       104.7  
     Interest income, net increased $1.7 million and $3.5 million during the three and six month periods ended June 30, 2007, respectively, mainly as a result of higher average cash and cash equivalent balances in 2007.
Provision for Income Taxes (dollars in millions)
                                   
    Three Months Ended   Six Months Ended
    June 30,   June 30,
    2007   2006     2007   2006
Provision for income taxes
  $ 8.7     $ 12.0       $ 20.6     $ 19.9  
     Our effective tax rate for the three and six month periods ended June 30, 2007 was 27.9% and 29.2%, respectively. The effective tax rate is less than the statutory tax rate primarily due to the profits of our international subsidiaries being taxed at rates lower than the U.S. statutory tax rate and the benefit from U.S. research and development credits.
     Our effective tax rate for the three and six month periods ended June 30, 2006 was 33.0% and 33.3%, respectively. The effective tax rate is less than the statutory tax rate primarily due to the profits of our international subsidiaries being taxed at rates lower than the U.S. statutory tax rate.
     We have adopted FASB Interpretation 48, Accounting for Uncertainty in Income Taxes (“FIN 48”), as of January 1, 2007. As a result of the implementation of FIN 48, we did not recognize an adjustment in the liability for unrecognized income tax benefits. At the adoption date of January 1, 2007, the total amount of gross unrecognized tax benefits, which excludes interest and penalties discussed below, was $10.5 million. If these benefits were recognized in a future period, the timing of which is not estimable, the net unrecognized tax benefit of $10.1 million would impact our effective tax rate. The total amount of gross unrecognized tax benefits at June 30, 2007 was approximately $11.7 million. The increase from January 1, 2007 was primarily attributable to our tax positions taken during the current year.
     MKS and its subsidiaries are subject to U.S. federal income tax as well as the income tax of multiple state and foreign jurisdictions. We have concluded all U.S. federal income tax matters for years through 2002. As of June 30, 2007, there were ongoing audits in various other tax jurisdictions. We do not expect any material changes to the returns as filed from these open audits.
     Within the next four quarters, the statute of limitations will close on our 2001 and 2002 tax returns filed in various foreign jurisdictions. As a result, it is reasonably expected that net unrecognized tax benefits from these foreign jurisdictions may be recognized in the next four quarters. The recognition of these tax benefits is not expected to have a material impact on our financial statements. We do not reasonably expect any other significant changes in the next four quarters. The following tax years, in the major tax jurisdictions noted, are open for assessment or refund: U.S. Federal: 2003 to 2006, Germany: 2002 to 2006, Korea: 2005 and 2006, Japan: 2001 to 2006, and the United Kingdom: 2005 and 2006.
     We will accrue interest and, if applicable, penalties, for any uncertain tax positions. This interest and penalty expense will be a component of income tax expense. At the date of adoption of FIN 48 and at June 30, 2007, we had $0.7 million and $1.0 million, respectively, accrued for interest on unrecognized tax benefits.
     The U.S. Research and Development Tax Credit expired at the end of 2005 and was not reinstated until late in the fourth quarter of 2006. As a result, we did not take any benefit for this credit in the three and six month periods ending June 30, 2006 and recorded a retroactive adjustment for fiscal 2006 in the fourth quarter. The benefits taken in the three and six month periods ending June 30, 2007 for this credit were approximately $0.5 million and $0.8 million, respectively.
Liquidity and Capital Resources
     Cash, cash equivalents and short-term investments totaled $336.1 million at June 30, 2007 compared to $290.0 million at December 31, 2006. The primary source of funds for the first six months of fiscal 2007 was cash provided by operating activities of $45.2 million.
     Net cash provided by operating activities of $45.2 million for the six months ended June 30, 2007, resulted mainly from net income of $49.8 million, non-cash charges of $15.4 million for depreciation and amortization and $8.4 million for stock-based compensation and related tax benefits, offset by an increase in net operating assets of $21.7 million and an $8.2 million decrease in net operating liabilities. The

14


Table of Contents

$21.7 million increase in net operating assets consisted primarily of a $14.2 million increase in inventory, to support our increased revenues and to support the increased inventory levels required for our planned China facility relocation in the second half of 2007, and a $4.8 million increase in other current assets, primarily related to prepaid taxes. The decrease in net operating liabilities of $8.2 million is mainly caused by a decrease of $16.7 million in current income taxes payable, primarily due to payments of estimated U.S. taxes, offset by an increase of $8.9 million in accrued expenses and other liabilities. Net cash provided by operating activities of $24.8 million for the six months ended June 30, 2006, resulted mainly from net income of $39.8 million, a $13.1 million increase in net operating liabilities and non-cash charges of $15.9 million for depreciation and amortization and $8.0 million for stock-based compensation and related tax benefits, offset by an increase in net operating assets of $52.9 million. The increase in net operating liabilities is mainly caused by an increase of $11.6 million in accrued expenses and other current liabilities, primarily as a result of higher accrued compensation and warranty costs, an increase of $4.4 million in accounts payable, primarily as a result of inventory procurement activities, offset by a decrease of $2.9 million in income taxes payable. The $52.9 million increase in net operating assets consisted primarily of a $28.4 million increase in accounts receivable as a result of higher revenue and a $24.0 million increase in inventory as a result of increased product demand.
     Net cash used in investing activities of $50.4 million for the six months ended June 30, 2007, resulted primarily from net purchases of $44.1 million of available for sale investments. Net cash used in investing activities of $81.4 million for the six months ended June 30, 2006, resulted primarily from the purchase of two technology companies for $96.7 million, offset by the net maturities of $20.2 million of available for sale investments.
     Net cash provided by financing activities of $10.7 million for the six months ended June 30, 2007, consisted primarily of $39.0 million in proceeds from the exercise of stock options and purchases under our employee stock purchase plan, offset by repurchases of common stock of $31.7 million. Net cash provided by financing activities of $22.5 million for the six months ended June 30, 2006, consisted primarily of $16.6 million in proceeds from the exercise of stock options and purchases under our employee stock purchase plan and $6.1 million in net proceeds from short-term borrowings.
     On February 12, 2007, our Board of Directors approved a share repurchase program (the “Program”) for the repurchase of up to $300 million of our outstanding stock over two years. The repurchases may be made from time to time on the open market or through privately negotiated transactions. The timing and amount of any shares repurchased under the Program will depend on a variety of factors, including price, corporate and regulatory requirements, capital availability, and other market conditions. The Program may be discontinued at any time at the discretion of the Company and our Board of Directors. During the six months ended June 30, 2007, we repurchased 1.2 million shares of common stock for $31.7 million for an average price of $26.42.
     We believe that our working capital, together with the cash anticipated to be generated from operations, will be sufficient to satisfy our estimated working capital, stock repurchase program activity and planned capital expenditure requirements through at least the next 12 months.
     To the extent permitted by Massachusetts law, our Restated Articles of Organization, as amended, require us to indemnify any of our current or former officers or directors or any person who has served or is serving in any capacity with respect to any of our employee benefit plans. Because no claim for indemnification has been pursued by any person covered by the relevant provisions of our Restated Articles of Organization, we believe that the estimated exposure for these indemnification obligations is currently minimal. Accordingly, we have no liabilities recorded for these requirements as of June 30, 2007.
     We also enter into agreements in the ordinary course of business which include indemnification provisions. Pursuant to these agreements, we indemnify, hold harmless and agree to reimburse the indemnified party, generally our customers, for losses suffered or incurred by the indemnified party in connection with certain patent or other intellectual property infringement claims, and, in some instances, other claims, by any third party with respect to our products. The terms of these indemnification obligations are generally perpetual after execution of the agreements. The maximum potential amount of future payments we could be required to make under these indemnification agreements is, in some instances, not contractually limited. We have never incurred costs to defend lawsuits or settle claims related to these indemnification obligations. As a result, we believe the estimated fair value of these obligations is minimal. Accordingly, we have no liabilities recorded for these obligations as of June 30, 2007.
     When, as part of an acquisition, we acquire all of the stock or all of the assets and liabilities of another company, we assume liability for certain events or occurrences that took place prior to the date of acquisition. The maximum potential amount of future payments we could be required to make for such obligations is undeterminable at this time. Other than obligations recorded as liabilities at the time of the acquisitions, historically we have not made significant payments for these indemnifications. Accordingly, no liabilities have been recorded for these obligations as of June 30, 2007.
     In conjunction with certain asset sales, we may provide routine indemnifications whose terms range in duration and often are not explicitly defined. Where appropriate, an obligation for such indemnifications is recorded as a liability. Because the amounts of liability under these types of indemnifications are not explicitly stated, the overall maximum amount of the obligation under such indemnifications

15


Table of Contents

cannot be reasonably estimated. Other than obligations recorded as liabilities at the time of the asset sale, historically we have not made significant payments for these indemnifications.
Off-Balance Sheet Arrangements
     We do not have any financial partnerships with unconsolidated entities, such as entities often referred to as structured finance, special purpose entities or variable interest entities, which are often established for the purpose of facilitating off-balance sheet arrangements or for other contractually narrow or limited purposes. Accordingly, we are not exposed to any financing, liquidity, market or credit risk that could arise if we had such relationships.
Recently Issued Accounting Pronouncements
     In September 2006, the FASB issued SFAS No. 157, “Fair Value Measurements” (“SFAS 157”). SFAS 157 clarifies the principle that fair value should be based on the assumptions market participants would use when pricing an asset or liability and establishes a fair value hierarchy that prioritizes the information used to develop those assumptions. Under the standard, fair value measurements would be separately disclosed by level within the fair value hierarchy. SFAS 157 is effective for fiscal years beginning after November 15, 2007, with early adoption permitted. We are in the process of evaluating any potential impact of SFAS 157.
     In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Liabilities” (“SFAS 159”). SFAS 159 permits companies to choose to measure certain financial instruments and certain other items at fair value and requires that unrealized gains and losses on items for which the fair value option has been elected be reported in earnings. SFAS 159 is effective for fiscal years beginning after November 15, 2007, although early adoption is permitted. We are currently evaluating the impact of SFAS 159 and have not yet determined its possible effect on our consolidated financial statements.
     ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
     Information concerning market risk is contained in the Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in our Annual Report on Form 10-K for the year ended December 31, 2006 filed with the Securities and Exchange Commission on February 28, 2007. There were no material changes in our exposure to market risk from December 31, 2006.
     ITEM 4. CONTROLS AND PROCEDURES.
a) Effectiveness of disclosure controls and procedures.
     MKS’ management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2007. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (“the Exchange Act”), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by the company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of June 30, 2007, our chief executive officer and chief financial officer concluded that, as of such date, MKS’ disclosure controls and procedures were effective at the reasonable assurance level.
b) Changes in internal control over financial reporting.
     There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended June 30, 2007 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

16


Table of Contents

PART II. OTHER INFORMATION
     ITEM 1. LEGAL PROCEEDINGS.
     We are subject to various legal proceedings and claims, which have arisen in the ordinary course of business. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on our results of operations, financial condition or cash flows.
     ITEM 1A. RISK FACTORS.
     Information regarding risk factors affecting the Company’s business are discussed in the Company’s Annual Report of Form 10-K for the year ended December 31, 2006 in the section entitled “Risk Factors.” As of June 30, 2007, there have been no material changes from those risk factors.
     ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
     The following table provides information about purchases by MKS during the quarter ended June 30, 2007, of equity securities that are registered by MKS pursuant to Section 12 of the Exchange Act:
ISSUER PURCHASES OF EQUITY SECURITIES
                                 
                            (d)
                    (c)   Maximum Number (or
                    Total Number of   Approximate Dollar
                Shares (or Units)   Value) of Shares
    (a)           Purchased as Part   (or Units) that May
    Total Number of   (b)   of Publicly   Yet Be Purchased
    Shares (or Units)   Average Price Paid   Announced Plans or   Under the Plans or
Period   Purchased 1   per Share (or Unit)   Programs1   Programs2
4/1/07 — 4/30/07
        $ 25.24       510,000     $ 287,125,203  
5/1/07 — 5/31/07
    265,000     $ 26.97       775,000     $ 279,976,858  
6/1/07 — 6/30/07
    425,765     $ 27.47       1,200,765     $ 268,280,916  
 
1)   We repurchased an aggregate of 1,200,765 shares of our common stock pursuant to the repurchase program that we publicly announced on February 12, 2007 (the “Program”).
 
2)   Our board of directors approved the repurchase by us of up to an aggregate of $300 million of our common stock pursuant to the Program. The expiration date of this Program is February 11, 2009, unless terminated earlier by resolution of our board of directors.
     ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
At our Annual Meeting of Shareholders on May 7, 2007, the following proposals were voted upon as further specified below:
          1. Election of Class II Directors:
                 
    Votes For   Votes Withheld
Cristina H. Amon
    52,129,867       955,233  
Richard S. Chute
    36,900,159       16,184,941  
          2. Ratification of PricewaterhouseCoopers LLP as our independent auditors:
                 
Votes For   Votes Against   Votes Abstaining
53,000,848
    53,921       30,331  

17


Table of Contents

     ITEM 6. EXHIBITS.
         
Exhibit No.   Exhibit Description
  3.1 (1)  
Restated Articles of Organization
       
 
  3.2 (2)  
Articles of Amendment, as filed with the Secretary of State of Massachusetts on May 18, 2001
       
 
  3.3 (3)  
Articles of Amendment, as filed with the Secretary of State of Massachusetts on May 16, 2002
       
 
  3.4 (4)  
Amended and Restated By-Laws
       
 
  31.1    
Certification of Principal Executive Officer pursuant to Rule 13a-14(a)/Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended
       
 
  31.2    
Certification of Principal Financial Officer pursuant to Rule 13a-14(a)/Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended
       
 
  32.1    
Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
(1)   Incorporated by reference to the Registration Statement on Form S-4 (File No. 333-49738) filed with the Securities and Exchange Commission on November 13, 2000.
 
(2)   Incorporated by reference to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2001.
 
(3)   Incorporated by reference to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2002.
 
(4)   Incorporated by reference to the Registration Statement on Form S-1 filed with the Securities and Exchange Commission on January 28, 1999, as amended.
SIGNATURE
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
         
  MKS INSTRUMENTS, INC.
 
 
August 8, 2007  By:   /s/ Ronald C. Weigner    
    Ronald C. Weigner   
    Vice President and Chief Financial Officer (Principal Financial Officer)   
 

18

exv31w1
 

EXHIBIT 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO RULE 13a-14(a)/RULE 15d-14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934, AS AMENDED
I, Leo Berlinghieri, certify that:
1.   I have reviewed this report on Form 10-Q of MKS Instruments, Inc.;
 
2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.   The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:
  a)   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
  b)   Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
  c)   Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
  d)   Disclosed in this report any changes in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.   The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
  a)   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
  b)   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control and financial reporting.
         
     
Date: August 8, 2007  /s/ Leo Berlinghieri    
  Leo Berlinghieri   
  Chief Executive Officer and President
(Principal Executive Officer) 
 
 

exv31w2
 

EXHIBIT 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO RULE 13a-14(a)/RULE 15d-14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934, AS AMENDED
I, Ronald C. Weigner, certify that:
1.   I have reviewed this report on Form 10-Q of MKS Instruments, Inc.;
 
2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.   The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:
  a)   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
  b)   Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
  c)   Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
  d)   Disclosed in this report any changes in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.   The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
  a)   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
  b)   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control and financial reporting.
         
     
Date: August 8, 2007  /s/ Ronald C. Weigner    
  Ronald C. Weigner   
  Vice President and Chief Financial Officer (Principal Financial Officer)   
 

exv32w1
 

EXHIBIT 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
     In connection with the Quarterly Report on Form 10-Q of MKS Instruments, Inc. (the “Company”) for the period ended June 30, 2007 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Leo Berlinghieri, Chief Executive Officer and President of the Company, and Ronald C. Weigner, Vice President and Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, based on his knowledge:
  (1)   The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
  (2)   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
         
     
Dated: August 8, 2007  /s/ Leo Berlinghieri    
  Leo Berlinghieri   
  Chief Executive Officer and President   
 
     
Dated: August 8, 2007  /s/ Ronald C. Weigner    
  Ronald C. Weigner   
  Vice President and Chief Financial Officer